Primary Cells

Human Acute Lymphoid Leukemia Peripheral Blood CD19+ B Cells (Relapsed/Refractory)

  • For research use only

Cat No.

ABC-TC3013

Product Type

Immune Cells

Cell Type

B Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Storage

Liquid Nitrogen

Explore Human Acute Lymphoid Leukemia Peripheral Blood CD19+ B Cells to model relapsed leukemia, test B-cell markers, and screen treatments.

Product Image

Description

Acute Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19+ B cells are available in the newly diagnosed and relapsed/refractory stages.

Species

Human

Cat.No

ABC-TC3013

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

B Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Acute Lymphoid Leukemia Peripheral Blood CD19+ B Cells (Relapsed/Refractory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button